2009年
1. Matsuura K, Tanaka Y, Hasegawa I, Ohno T, Tokuda H, Kurbanov F, Sugauchi F, Nojiri S, Joh T, Mizokami M. Abbott Realtime Hepatitis C Virus (Hcv) and Roche Cobas Ampliprep/Cobas Taqman Hcv Assays for Prediction of Sustained Virological Response to Pegylated Interferon and Ribavirin in Chronic Hepatitis C Patients. J Clin Microbiol 47 (2): 385-9 2009.02
2. Sugiyama M, Tanaka Y, Kurbanov F, Maruyama I, Shimada T, Takahashi S, Shirai T, Hino K, Sakaida I, Mizokami M. Direct Cytopathic Effects of Particular Hepatitis B Virus Genotypes in Severe Combined Immunodeficiency Transgenic with Urokinase-Type Plasminogen Activator Mouse with Human Hepatocytes. Gastroenterology 136 (2): 652-62 e3 2009.02
3. Ito K, Kim KH, Lok AS, Tong S. Characterization of Genotype-Specific Carboxyl-Terminal Cleavage Sites of Hepatitis B Virus E Antigen Precursor and Identification of Furin as the Candidate Enzyme. J Virol 83 (8): 3507-17 2009.04
4. Matsuura K, Tanaka Y, Hige S, Yamada G, Murawaki Y, Komatsu M, Kuramitsu T, Kawata S, Tanaka E, Izumi N, Okuse C, Kakumu S, Okanoue T, Hino K, Hiasa Y, Sata M, Maeshiro T, Sugauchi F, Nojiri S, Joh T, Miyakawa Y, Mizokami M. Distribution of Hepatitis B Virus Genotypes among Patients with Chronic Infection in Japan Shifting toward an Increase of Genotype A. J Clin Microbiol 47 (5): 1476-83 2009.05
5. Nozaki Y, Yanase M, Masaki N. Usefulness of Positron Emission and Computed Tomography Scan in Early Evaluation of Treatment Response in Gastrointestinal Stromal Tumor. Clin Gastroenterol Hepatol 8 (3): A22 2009.05
6. Elkady A, Tanaka Y, Kurbanov F, Sugauchi F, Sugiyama M, Khan A, Sayed D, Moustafa G, Abdel-Hameed AR, Mizokami M. Genetic Variability of Hepatitis C Virus in South Egypt and Its Possible Clinical Implication. J Med Viro l81 (6): 1015-23 2009.06
7. Khan A, Tanaka Y, Azam Z, Abbas Z, Kurbanov F, Saleem U, Hamid S, Jafri W, Mizokami M. Epidemic Spread of Hepatitis C Virus Genotype 3a and Relation to High Incidence of Hepatocellular Carcinoma in Pakistan. J Med Virol 81 (7): 1189-97 2009.07
8. Kusakabe A, Tanaka Y, Mochida S, Nakayama N, Inoue K, Sata M, Isoda N, Kang JH, Sumino Y, Yatsuhashi H, Takikawa Y, Kaneko S, Yamada G, Karino Y, Tanaka E, Kato J, Sakaida I, Izumi N, Sugauchi F, Nojiri S, Joh T, Miyakawa Y, Mizokami M. Case-Control Study for the Identification of Virological Factors Associated with Fulminant Hepatitis B. Hepatol Res 39 (7): 648-56 2009.07
9. Tanaka Y, Nishida N, Sugiyama M, Kurosaki M, Matsuura K, Sakamoto N, Nakagawa M, Korenaga M, Hino K, Hige S, Ito Y, Mita E, Tanaka E, Mochida S, Murawaki Y, Honda M, Sakai A, Hiasa Y, Nishiguchi S, Koike A, Sakaida I, Imamura M, Ito K, Yano K, Masaki N, Sugauchi F, Izumi N, Tokunaga K, Mizokami M. Genome-Wide Association of Il28b with Response to Pegylated Interferon-Alpha and Ribavirin Therapy for Chronic Hepatitis C. Nat Genet 41 (10): 1105-9 2009.10
10. Tatematsu K, Tanaka Y, Kurbanov F, Sugauchi F, Mano S, Maeshiro T, Nakayoshi T, Wakuta M, Miyakawa Y, Mizokami M. A Genetic Variant of Hepatitis B Virus Divergent from Known Human and Ape Genotypes Isolated from a Japanese Patient and Provisionally Assigned to New Genotype J. J Virol 83 (20): 10538-47 2009.10
共著論文
1. Yuen MF, Tanaka Y, Fong DY, Fung J, Wong DK, Yuen JC, But DY, Chan AO, Wong BC, Mizokami M, Lai CL. Independent Risk Factors and Predictive Score for the Development of Hepatocellular Carcinoma in Chronic Hepatitis B. J Hepatol 50 (1): 80-8 2009.01
2. Kurahashi N, Inoue M, Iwasaki M, Tanaka Y, Mizokami M, Tsugane S. Vegetable, Fruit and Antioxidant Nutrient Consumption and Subsequent Risk of Hepatocellular Carcinoma: A Prospective Cohort Study in Japan. Br J Cancer 100 (1): 181-4 2009.01.13
3. Ishiguro S, Inoue M, Tanaka Y, Mizokami M, Iwasaki M, Tsugane S. Serum Aminotransferase Level and the Risk of Hepatocellular Carcinoma: A Population-Based Cohort Study in Japan. Eur J Cancer Prev 18 (1): 26-32 2009.02
4. Madan K, Batra Y, Sreenivas V, Mizokami M, Tanaka Y, Chalamalasetty SB, Panda SK, Acharya SK. Hbv Genotypes in India: Do They Influence Disease Severity? Hepatol Res 39 (2): 157-63 2009.02
5. Ito H, Kuno A, Sawaki H, Sogabe M, Ozaki H, Tanaka Y, Mizokami M, Shoda J, Angata T, Sato T, Hirabayashi J, Ikehara Y, Narimatsu H. Strategy for Glycoproteomics: Identification of Glyco-Alteration Using Multiple Glycan Profiling Tools. J Proteome Res 8 (3): 1358-67 2009.03
6. Ikegami T, Matsuki Y, Tanaka Y, Mizokami M, Honda A, Hirayama T, Saito Y, Matsuzaki Y. Impact of Determination of Hepatitis B Virus Subgenotype and Pre-Core/Core-Promoter Mutation for the Prediction of Acute Exacerbation of Asymptomatic Carriers. Hepatol Res 39 (4): 341-5 2009.04
7. Kurahashi N, Inoue M, Iwasaki M, Tanaka Y, Mizokami M, Tsugane S. Isoflavone Consumption and Subsequent Risk of Hepatocellular Carcinoma in a Population-Based Prospective Cohort of Japanese Men and Women. Int J Cancer 124 (7): 1644-9 2009.04.01
8. Inoue M, Kurahashi N, Iwasaki M, Shimazu T, Tanaka Y, Mizokami M, Tsugane S. Effect of Coffee and Green Tea Consumption on the Risk of Liver Cancer: Cohort Analysis by Hepatitis Virus Infection Status. Cancer Epidemiol Biomarkers Prev 18 (6): 1746-53 2009.06
9. Inoue M, Kurahashi N, Iwasaki M, Tanaka Y, Mizokami M, Noda M, Tsugane S. Metabolic Factors and Subsequent Risk of Hepatocellular Carcinoma by Hepatitis Virus Infection Status: A Large-Scale Population-Based Cohort Study of Japanese Men and Women (Jphc Study Cohort Ii). Cancer Causes Control 20 (5): 741-50 2009.07
10. Kusumoto S, Tanaka Y, Mizokami M, Ueda R. Reactivation of Hepatitis B Virus Following Systemic Chemotherapy for Malignant Lymphoma. Int J Hematol 90 (1): 13-23 2009.07
11. Hashikura Y, Ichida T, Umeshita K, Kawasaki S, Mizokami M, Mochida S, Yanaga K, Monden M, Kiyosawa K. Donor Complications Associated with Living Donor Liver Transplantation in Japan. Transplantation 88 (1): 110-4 2009.07.15
12. Fung J, Lai CL, Tanaka Y, Mizokami M, Yuen J, Wong DK, Yuen MF. The Duration of Lamivudine Therapy for Chronic Hepatitis B: Cessation Vs. Continuation of Treatment after Hbeag Seroconversion. Am J Gastroenterol 104 (8): 1940-6; quiz 1947 2009.08
13. Aly HH, Qi Y, Atsuzawa K, Usuda N, Takada Y, Mizokami M, Shimotohno K, Hijikata M. Strain-Dependent Viral Dynamics and Virus-Cell Interactions in a Novel in Vitro System Supporting the Life Cycle of Blood-Borne Hepatitis C Virus. Hepatology 50 (3): 689-96 2009.09
14. Nozaki Y, Fujita K, Yoneda M, Wada K, Shinohara Y, Takahashi H, Kirikoshi H, Inamori M, Kubota K, Saito S, Mizoue T, Masaki N, Nagashima Y, Terauchi Y, Nakajima A. Long-Term Combination Therapy of Ezetimibe and Acarbose for Non-Alcoholic Fatty Liver Disease. J Hepatol 51 (3): 548-56 2009.09
15. Garcia T, Li J, Sureau C, Ito K, Qin Y, Wands J, Tong S. Drastic Reduction in the Production of Subviral Particles Does Not Impair Hepatitis B Virus Virion Secretion. J Virol 83 (21): 11152-65 2009.11
